The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Increase of Brain Oxidative Stress in Mild Cognitive Impairment: A Possible Predictor of Alzheimer Disease
Open accessAbstract
BACKGROUND: The isoprostane 8,12-iso-iPF(2alpha)-VI, a specific marker of in vivo lipid peroxidation, is increased in Alzheimer disease (AD). The pathological changes associated with AD have a long silent phase before the appearance of clinical symptoms. Several studies have shown that AD is preceded by a prodromal phase characterized by mild cognitive impairment (MCI). OBJECTIVE: To investigate levels of this biomarker in subjects with MCI. DESIGN AND MAIN OUTCOME MEASURES: Using gas chromatography-mass spectrometry analysis, we measured 8,12-iso-iPF(2alpha)-VI levels in urine, plasma, and cerebrospinal fluid of patients with AD, subjects with MCI, and cognitively normal elderly subjects. SETTING AND PATIENTS: Subjects attending the Memory Disorders Clinic. RESULTS: We found significantly higher 8,12-iso-iPF(2alpha)-VI levels in cerebrospinal fluid, plasma, and urine of subjects with MCI compared with cognitively normal elderly subjects. CONCLUSIONS: These results imply that individuals with MCI have increased brain oxidative damage before the onset of symptomatic dementia. Measurement of this isoprostane may identify a subgroup of patients with MCI with increased lipid peroxidation who are at increased risk to progress to symptomatic AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404
Guitton, D., Buchtel, H. A., & Douglas, R. M. (1985) · Experimental Brain Research · doi:10.1007/bf00235863 · Cited by 1,005
Welsh, K. A., Butters, N., Mohs, R. C., Beekly, D., Edland, S., Fillenbaum, G., & Heyman, A. (1994) · Neurology · doi:10.1212/wnl.44.4.609 · Cited by 951
Mild cognitive impairment in the elderly: Predictors of dementia
Flicker, C., Ferris, S. H., & Reisberg, B. (1991) · Neurology · doi:10.1212/wnl.41.7.1006 · Cited by 838
Petersen, R. C. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520400044042 · Cited by 780
Corticodentatonigral Degeneration With Neuronal Achromasia
Rebeiz, J. J., Kolodny, E. H., & Richardson, E. P. (1968) · Archives of Neurology · doi:10.1001/archneur.1968.00470310034003 · Cited by 627
CORTICAL CONTROL OF REFLEXIVE VISUALLY-GUIDED SACCADES
PIERROT-DESEILLIGNY, C., RIVAUD, S., GAYMARD, B., & AGID, Y. (1991) · Brain · doi:10.1093/brain/114.3.1473 · Cited by 596
Increased F 2 ‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo
Pratico, D., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & Fitzgerald, G. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1777 · Cited by 405 · cited 12×
“This observation was confirmed by Tuppo et al,21 who measured urinary levels of another distinct F2-isoprostane, iPF2 -III, in patients with AD.”
BackgroundInfluentialSelf-citationPredicting Conversion to Alzheimer Disease Using Standardized Clinical Information
Daly, E., Zaitchik, D., Copeland, M., Schmahmann, J., Gunther, J., & Albert, M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.5.675 · Cited by 360
Pratic�, D., Clark, C. M., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & FitzGerald, G. A. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<809::aid-ana19>3.0.co;2-9 · Cited by 348
Self-citationFeinberg, T. E., Schindler, R. J., Flanagan, N. G., & Haber, L. D. (1992) · Neurology · doi:10.1212/wnl.42.1.19 · Cited by 304
Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease
Arai, H., Terajima, M., Miura, M., Higuchi, S., Muramatsu, T., Machida, N., Seiki, H., Takase, S., Clark, C. M., Lee, V. M. ‐., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380414 · Cited by 298
Self-citationAndreasen, N., Minthon, L., Vanmechelen, E., Vanderstichele, H., Davidsson, P., Winblad, B., & Blennow, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00617-5 · Cited by 239
Cerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's disease
Montine, T. J., Markesbery, W. R., Morrow, J. D., & Roberts, L. J. (1998) · Annals of Neurology · doi:10.1002/ana.410440322 · Cited by 239
Clark, C. M., & Ewbank, D. C. (1996) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199601010-00006 · Cited by 222
Self-citationF2-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo
Praticò, D. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00257-9 · Cited by 165
Self-citationTierney, M. C., Szalai, J. P., Snow, W. G., Fisher, R. H., Tsuda, T., Chi, H., McLachlan, D. R. C., & George‐Hyslop, P. S. (1996) · Neurology · doi:10.1212/wnl.46.1.149 · Cited by 162
Mild cognitive impairment. When is it a precursor to Alzheimer's disease?
Shah, Y., Tangalos, E. G., & Petersen, R. C. (2000) · PubMed · Cited by 122
Amyloid Precursor Protein and Amyloid β Peptide in Human Platelets
Skovronsky, D., Lee, V. M. ‐., & Praticò, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006285200 · Cited by 121
Self-citationCognitive Impairment with No Dementia (CIND): Longitudinal Studies, the Findings, and the Issues
Tuokko, H. A., & Frerichs, R. J. (2000) · The Clinical Neuropsychologist · doi:10.1076/clin.14.4.504.7200 · Cited by 100
Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer’s disease
Tuppo, E. E., FORMAN, L. J., Spur, B. W., Chan-Ting, R. E., Chopra, A., & Cavalieri, T. A. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00450-6 · Cited by 91
Lawson, J. A., Li, H., Rokach, J., Adiyaman, M., Hwang, S., Khanapure, S. P., & FitzGerald, G. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29295 · Cited by 82
Verfaellie, M. H., & Heilman, K. M. (1990) · Brain and Cognition · doi:10.1016/0278-2626(90)90061-r · Cited by 51
The anarchic hand: a frontomesial sign
Sala, S. D., Marchetti, C., & Spinnler, H. R. (1994) · Cited by 46
Unilateral Hemispheric Injury and Ipsilateral Instinctive Grasp Reaction
Mori, E., & Yamadori, A. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060050087014 · Cited by 33
Praticò, D., Clark, C. M., Lee, V. M. ‐., Trojanowski, J. Q., Rokach, J., & FitzGerald, G. A. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<809::aid-ana19>3.3.co;2-0 · Cited by 7
Self-citation(2000) · doi:10.1002/1531-8249(200012)48:6
Cited by
Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Halliwell, B., & Whiteman, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705776 · Cited by 2,238
Biomarkers of Oxidative Damage in Human Disease
Dalle-Donne, I., Rossi, R., Colombo, R., Giustarini, D., & Milzani, A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.061408 · Cited by 1,703
The Alzheimer's Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.008 · Cited by 1,525
Self-citationOxidative stress and mitochondrial dysfunction in Alzheimer’s disease
Wang, X., Wang, W., Li, L., Perry, G., Lee, H.-G., & Zhu, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.015 · Cited by 1,357
Metadata
- Authors
- Praticò, D., Clark, C. M., Liun, F., Lee, V. Y.-M., & Trojanowski, J. Q.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2002-06-01
- Volume
- 59
- Issue
- 6
- Pages
- 972
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2103163836
- Cited by
- 584
- References
- 29
- FWCI
- 16.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.